Type 1 antiarrhythmic

This page covers all Type 1 antiarrhythmic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cardiac sodium channels; cardiac cells with augmented automaticity.

Targets

Cardiac sodium channels; cardiac cells with augmented automaticity

Marketed (1)

• Norpace Cr · Pfizer
  Type 1 antiarrhythmic that decreases diastolic depolarization and increases action potential duration.

Patent intelligence

• type 1 antiarrhythmic patent landscape — aggregated cliff calendar, attackable patents, originator estates